Abstract
Due to the limited time pass (less than 5 years) for developing CRISPR/Cas-based electrochemical detection platforms, this field is very new. The number of experimental studies is limited, and this field does not take a long developmental path yet. Therefore expansion of ideas is limited based on some pioneering research. However, this does not diminish the importance and potential of this field. There is vast potential in the field of CRISPR/Cas-based diagnostics; as the electrochemical detection systems proved their abilities in the past, merging these two categories will mark a bright future with applications in very diverse subjects. This chapter attempts to brighten the potential of applications in this field. Despite the limited number of researches in this field, the diverse application of CRISPR/Cas-based electrochemical biosensors are reviewed here, which implicitly confirms the potential of this field. Due to the analytical advantage of the electrochemical-based detection system, in comparison to the other methods, electrochemical CRISPR/Cas-based detection systems will significantly impact improving public health quality through developing sensitive, reliable, and affordable point of care diagnostic devices and tests.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
